Search details
1.
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
BMC Cancer
; 24(1): 430, 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38589857
2.
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.
Cancer Immunol Immunother
; 72(7): 2217-2231, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36869232
3.
The role of opioids in cancer response to immunotherapy.
J Transl Med
; 19(1): 119, 2021 03 23.
Article
in English
| MEDLINE | ID: mdl-33757546
4.
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era.
J Transl Med
; 19(1): 303, 2021 07 12.
Article
in English
| MEDLINE | ID: mdl-34253248
5.
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience.
Anticancer Drugs
; 31(10): 1074-1083, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32932276
6.
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
BMC Cancer
; 24(1): 487, 2024 Apr 17.
Article
in English
| MEDLINE | ID: mdl-38632499
7.
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan.
Oral Dis
; 28 Suppl 1: 970-972, 2022 04.
Article
in English
| MEDLINE | ID: mdl-32930434
8.
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
Lancet Oncol
; 16(13): 1306-15, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26338525
9.
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy.
Br J Clin Pharmacol
; 77(6): 929-38, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-23981115
10.
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors.
Front Immunol
; 14: 1199089, 2023.
Article
in English
| MEDLINE | ID: mdl-37483633
11.
The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma.
Cancers (Basel)
; 15(18)2023 Sep 15.
Article
in English
| MEDLINE | ID: mdl-37760556
12.
Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials.
Acta Oncol
; 51(7): 873-9, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22909392
13.
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology.
Front Oncol
; 12: 1092201, 2022.
Article
in English
| MEDLINE | ID: mdl-36686738
14.
Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up.
Diagnostics (Basel)
; 12(8)2022 Aug 02.
Article
in English
| MEDLINE | ID: mdl-36010214
15.
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.
Front Immunol
; 13: 974087, 2022.
Article
in English
| MEDLINE | ID: mdl-36405727
16.
Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile.
Biomedicines
; 10(11)2022 Oct 28.
Article
in English
| MEDLINE | ID: mdl-36359251
17.
Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer.
Cancers (Basel)
; 13(5)2021 Mar 03.
Article
in English
| MEDLINE | ID: mdl-33802438
18.
Myocardial Metastasis of Tongue Cancer: A Rare Localization.
Am J Case Rep
; 22: e927459, 2021 Feb 12.
Article
in English
| MEDLINE | ID: mdl-33574215
19.
The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study.
J Pers Med
; 11(7)2021 Jul 10.
Article
in English
| MEDLINE | ID: mdl-34357118
20.
Anti-PD-1 and Anti-PD-L1 in Head and Neck Cancer: A Network Meta-Analysis.
Front Immunol
; 12: 705096, 2021.
Article
in English
| MEDLINE | ID: mdl-34434192